company background image
524703 logo

Sandu Pharmaceuticals BSE:524703 Stock Report

Last Price

₹56.39

Market Cap

₹544.8m

7D

1.5%

1Y

-16.1%

Updated

20 Dec, 2024

Data

Company Financials

Sandu Pharmaceuticals Limited

BSE:524703 Stock Report

Market Cap: ₹544.8m

524703 Stock Overview

Manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. More details

524703 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Rewards

Trading at 24.7% below our estimate of its fair value

Earnings have grown 15% per year over the past 5 years

Risk Analysis

Does not have a meaningful market cap (₹545M)


My Notes

Capture your thoughts, links and company narrative

Sandu Pharmaceuticals Limited Competitors

Walpar Nutritions

NSEI:WALPAR

₹440.0m

Deccan Health Care

BSE:542248

₹623.3m

Lykis

BSE:530689

₹874.4m

Unjha Formulations

BSE:531762

₹136.7m

Price History & Performance

Summary of share price highs, lows and changes for Sandu Pharmaceuticals
Historical stock prices
Current Share Price₹56.39
52 Week High₹85.00
52 Week Low₹54.00
Beta0.70
1 Month Change-1.96%
3 Month Change-10.35%
1 Year Change-16.12%
3 Year Change14.50%
5 Year Change299.93%
Change since IPO651.87%

Recent News & Updates

Recent updates

Shareholder Returns

524703IN Personal ProductsIN Market
7D1.5%-2.6%-4.2%
1Y-16.1%-4.9%19.1%

Return vs Industry: 524703 underperformed the Indian Personal Products industry which returned -3.3% over the past year.

Return vs Market: 524703 underperformed the Indian Market which returned 22.5% over the past year.

Price Volatility

Is 524703's price volatile compared to industry and market?
524703 volatility
524703 Average Weekly Movement4.4%
Personal Products Industry Average Movement5.4%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 524703 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 524703's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1899283Umesh Sandusandu.in

Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. The company offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. It also provides mahasudarshan kadha, amritarishta, tab.

Sandu Pharmaceuticals Limited Fundamentals Summary

How do Sandu Pharmaceuticals's earnings and revenue compare to its market cap?
524703 fundamental statistics
Market cap₹544.78m
Earnings (TTM)₹14.61m
Revenue (TTM)₹677.67m

37.3x

P/E Ratio

0.8x

P/S Ratio

Is 524703 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524703 income statement (TTM)
Revenue₹677.67m
Cost of Revenue₹343.57m
Gross Profit₹334.10m
Other Expenses₹319.50m
Earnings₹14.61m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.51
Gross Margin49.30%
Net Profit Margin2.16%
Debt/Equity Ratio0%

How did 524703 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

53%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 15:09
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sandu Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution